Diminished HSD11B1 activity has been previously reported in PCOS [27,28,29,30] and may result in a shift of steroidogenesis towards the more active glucocorticoid products associated with hypercortisolemic adverse effects often manifesting as the metabolic syndrome. Here, HSD11B1 is linked to metabolic syndrome.